Related Experiment Videos
[An unusual case of multiple myeloma diagnosed by a noticeable decrease in the serum M-component level]
1Department of Internal Medicine, Faculty of Medicine, Kyoto University.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|December 1, 1996
Summary
This case report details a rare instance of multiple myeloma diagnosed by a drop in serum monoclonal immunoglobulin G (IgG) levels alongside Bence Jones protein escape, indicating diverse myeloma cell subpopulations.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Monoclonal gammopathy of undetermined significance (MGUS) can progress to multiple myeloma.
- Multiple myeloma is characterized by the proliferation of malignant plasma cells.
- Serum monoclonal protein levels and Bence Jones proteins in urine are key diagnostic markers.
Observation:
- A 61-year-old woman initially diagnosed with MGUS later developed indolent multiple myeloma.
- The patient exhibited a decrease in serum monoclonal IgG (kappa) levels concurrently with Bence Jones protein escape.
- Bone marrow examination revealed immature plasma cells, and immunofluorescence showed distinct subpopulations of plasma cells.
Findings:
- Myeloma cells demonstrated immunologically diverse subpopulations: some producing IgG (kappa) and others producing only kappa light chains.
- Approximately two-thirds of plasma cells showed this dual population characteristic.
- This specific pattern of Bence Jones escape associated with a decrease in serum M-component was previously undescribed.
Implications:
- The findings suggest that multiple myeloma can evolve from a single clone into heterogeneous subpopulations.
- This heterogeneity may impact treatment strategies and disease monitoring in multiple myeloma.
- Understanding these diverse myeloma cell subpopulations is crucial for accurate diagnosis and prognosis.